These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5346869)

  • 1. Pharmaco-biochemical studies on cytotoxic polyol derivates. I. Effects of 1-6-dibromo-1-6-dideoxy-dulcitol on sensitive, resistant and refractor tumours.
    Vályi-Nagy T; Jeney A; Szabó J; Szabó I; Institoris L
    Eur J Cancer (1965); 1969 Sep; 5(4):403-14. PubMed ID: 5346869
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of myelobromol on growth and metabolism of experimental tumours.
    Friborský V
    Ther Hung; 1969; 17(1):23-7. PubMed ID: 5820143
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of DBM on rat ascites tumors and antibody production.
    Irikura T; Kawasaki H; Enta R; Hasegawa Y
    Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):394-6. PubMed ID: 4314621
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
    Csányi E; Halász M
    Br J Cancer; 1967 Jun; 21(2):353-7. PubMed ID: 6028086
    [No Abstract]   [Full Text] [Related]  

  • 6. 1,6-Dibromo-1,6-dideoxy-dulcitol: a new antitumoral agent.
    Kellner B; Németh L; Horváth P; Insitóris L
    Nature; 1967 Jan; 213(5074):402-3. PubMed ID: 6029531
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased lifespan by the sequential treatment with improsulfan and cyclophosphamide in rats bearing Yoshida ascites sarcoma.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1913-6. PubMed ID: 184972
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the carrying molecule in the cross-resistance against sugar alcohol derivatives.
    Gáti E; Horváth IP
    Eur J Cancer (1965); 1969 Dec; 5(6):553-7. PubMed ID: 5386716
    [No Abstract]   [Full Text] [Related]  

  • 9. [The growth of experimental tumors on chicken chorioallantois under the effect of coplanar hetero-oligobases. 3].
    Rauen HM; Norpoth K; Böhm E; Bremer K
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 144(1):1-13. PubMed ID: 5592676
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolic acid: an anti-cancer compound with unusual properties.
    Carter SB; Franklin TJ; Jones DF; Leonard BJ; Mills SD; Turner RW; Turner WB
    Nature; 1969 Aug; 223(5208):848-50. PubMed ID: 5799033
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 12. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d'arco (Tabebuia avellanedae)].
    de Santana CF; de Lima Og; d' Albuquerque IL; Lacerda AL; Martins DG
    Rev Inst Antibiot (Recife); 1968 Dec; 8(1):89-94. PubMed ID: 5761014
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of improsulfan by the fractionated dose schedule on rat ascites tumors.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2668-72. PubMed ID: 189948
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineoplastic action of methylglyoxal.
    Jerzykowski T; Matuszewski W; Otrzonsek N; Winter R
    Neoplasma; 1970; 17(1):25-35. PubMed ID: 4315796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.